Moreover, the GITMO panel identified 2.0×106 CD34+ cells/kg as the minimum safe dose for ensuring rapid neutrophil and platelet recovery both in lymphoma and in MM patients to be achieved with a maximum number of 3 aphereses.11,12,31 These parameters and indicators applied to both chemomobilization and G-CSF alone strategies although the timing of CD34+ cells peak and doses of G-CSF are different and should be considered.25 The gene discussed is CSF3; the disease is Miyoshi myopathy.